公司资料
Immunome 股价、新闻与催化剂
- 股票代码:
- IMNM
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
28.08 USD (-5.85%)
收盘价
最后更新: 2026年8月20日
2.19B USD
市值
股价为何变动
As of Aug 20, 2026, IMNM closed down 5.85% at $28.08. No new same-company headline was identified in the current news window.
公司概览
业务概览
Immunome is a biotechnology company focused on antibody discovery and oncology, with a platform that seeks to translate immune recognition into therapeutic programs. Its story is about building value from discovery engines and targeted cancer biology.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Immunome sits in specialty biotechnology.
商业模式特征
The company depends on platform validation, clinical progress, and the ability to create differentiated oncology assets.
生物医药行业定位
Immunome is a platform oncology name whose valuation is sensitive to translational and strategic progress.
未来催化剂
- Immunome’s catalysts are its antibody-discovery platform and oncology pipeline, especially any update that shows the company can still produce differentiated assets. The next readout matters because the platform still needs to prove itself.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。